Tang Minghua, Frank Daniel N, Sherlock Laurie, Ir Diana, Robertson Charles E, Krebs Nancy F
*Section of Nutrition, Department of Pediatrics†Department of Infectious Disease, University of Colorado School of Medicine‡Children's Hospital Colorado, Aurora, CO.
J Pediatr Gastroenterol Nutr. 2016 Sep;63(3):379-85. doi: 10.1097/MPG.0000000000001154.
Iron therapy induces inflammation, which could decrease iron absorption. Increased exposure of iron in the gut could also alter microbiome file. Providing antioxidants such as vitamin E with iron therapy has been associated with reduced oxidative potential.
The aim of the present study was to test the efficacy of adding vitamin E to therapeutic iron therapy on iron repletion, inflammation markers, and gut microbiome in iron-deficient infants and toddlers.
This was a randomized, double-blind, control trial in which infants and toddlers (Denver, CO metro area) who were at risk of iron deficiency were screened. Eligible participants were randomized to receive iron therapy (6 mg · kg · day) plus placebo (n = 22) or iron (6 mg · kg · day) and vitamin E (18 mg/day, n = 14) for 8 weeks. Iron and inflammation status, and gut microbiome (16S sequencing) were analyzed in all participants before and after the treatment.
After 8 weeks of treatment, average serum ferritin level returned to normal for both iron + placebo and iron + vitamin E groups at 33.3 ± 20.2 and 33.5 ± 21.5 μg/L, respectively. Serum vitamin E concentration increased in iron + vitamin E group. No change over time was observed regarding serum interleukin-4, tumor necrosis factor-α, or fecal calprotectin. The relative abundance of the genus Roseburia (phylum Firmicutes), a butyrate producer, increased in the Fe + E group (Δ1.3%, P < 0.01). Also at the genus level, the genus Escherichia decreased by 1.2% on average among all participants (effect of time P = 0.01).
Using a therapeutic iron dose of 6 mg · kg · day is effective in treating iron deficiency during an 8-week period, without inducing persistent inflammatory response. Changes of the gut microbiome raised the possibility that antioxidant therapy in conjunction with therapeutic iron supplementation could potentially improve microbial community profiles in the intestinal tract.
铁疗法会引发炎症,这可能会降低铁的吸收。肠道中铁暴露的增加也可能改变微生物群谱。在铁疗法中提供抗氧化剂(如维生素E)与降低氧化潜能有关。
本研究的目的是测试在缺铁婴幼儿的治疗性铁疗法中添加维生素E对铁补充、炎症标志物和肠道微生物群的疗效。
这是一项随机、双盲对照试验,对有缺铁风险的婴幼儿(科罗拉多州丹佛市市区)进行筛查。符合条件的参与者被随机分为接受铁疗法(6毫克·千克·天)加安慰剂(n = 22)或铁(6毫克·千克·天)和维生素E(18毫克/天,n = 14)治疗8周。在治疗前后对所有参与者的铁和炎症状态以及肠道微生物群(16S测序)进行分析。
治疗8周后,铁+安慰剂组和铁+维生素E组的平均血清铁蛋白水平分别恢复正常,为33.3±20.2和33.5±21.5微克/升。铁+维生素E组的血清维生素E浓度升高。血清白细胞介素-4、肿瘤坏死因子-α或粪便钙卫蛋白随时间未观察到变化。在铁+维生素E组中,丁酸产生菌罗斯氏菌属(厚壁菌门)的相对丰度增加(Δ1.3%,P < 0.01)。同样在属水平上,所有参与者中大肠杆菌属平均下降了1.2%(时间效应P = 0.01)。
使用6毫克·千克·天的治疗性铁剂量在8周内有效治疗缺铁,且不会引发持续的炎症反应。肠道微生物群的变化增加了抗氧化疗法与治疗性铁补充相结合可能改善肠道微生物群落谱的可能性。